Figures & data
Figure 1. A. Giant cell tumor of the distal femur, treated with evacuation and cement filling. B. After 11 years, there were no signs of recurrence and no deleterious effects of the cement.
![Figure 1. A. Giant cell tumor of the distal femur, treated with evacuation and cement filling. B. After 11 years, there were no signs of recurrence and no deleterious effects of the cement.](/cms/asset/31c4b729-8671-4f33-bc26-fc3e73e7d61d/iort_a_11327420_f0001_b.gif)
Figure 2. A. Giant cell tumor of the proximal tibia filled with autologous and allogeneous bone. B. After 6 years, there were no signs of recurrence and there was good consolidation.
![Figure 2. A. Giant cell tumor of the proximal tibia filled with autologous and allogeneous bone. B. After 6 years, there were no signs of recurrence and there was good consolidation.](/cms/asset/b6fba9d5-ea8c-4d92-b93c-15681e19e3ce/iort_a_11327420_f0002_b.gif)
Figure 4. Recurrence-free survival by margin in 292 giant cell tumors of the extremities (upper line: wider; lower line: intralesional surgery).
![Figure 4. Recurrence-free survival by margin in 292 giant cell tumors of the extremities (upper line: wider; lower line: intralesional surgery).](/cms/asset/6a9f0871-cc42-4090-abb5-55625beee530/iort_a_11327420_f0004_b.gif)
Table 1. Comparison of clinical features and features of treatment with local recurrence rates
Table 2. Univariate and multivariate analyses of risk factors for recurrence (n = 294)
Figure 5. Recurrence-free survival after intralesional surgery (filling with cement or bone) in 194 giant cell tumors of the extremities (upper line: with cement; lower line: without cement).
![Figure 5. Recurrence-free survival after intralesional surgery (filling with cement or bone) in 194 giant cell tumors of the extremities (upper line: with cement; lower line: without cement).](/cms/asset/529c7ff5-f173-4d5e-8a4f-160e1eb678b9/iort_a_11327420_f0005_b.gif)
Table 3. Intralesional surgery: univariate analysis of cavity filling with cement vs. other